{"pmid":32338424,"title":"Biologics for psoriasis in COVID-19 era: what do we know?","text":["Biologics for psoriasis in COVID-19 era: what do we know?","Dermatol Ther","Megna, M","Napolitano, M","Patruno, C","Fabbrocini, G","32338424"],"journal":"Dermatol Ther","authors":["Megna, M","Napolitano, M","Patruno, C","Fabbrocini, G"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32338424","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/dth.13467","keywords":["covid-19","biologics","psoriasis"],"topics":["Prevention"],"weight":1,"_version_":1665264685558005760,"score":8.574329,"similar":[{"pmid":32283234,"pmcid":"PMC7146699","title":"Biologics for psoriasis during COVID-19 outbreak.","text":["Biologics for psoriasis during COVID-19 outbreak.","J Am Acad Dermatol","Di Lernia, Vito","32283234"],"journal":"J Am Acad Dermatol","authors":["Di Lernia, Vito"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283234","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaad.2020.04.004","keywords":["covid-19","biologics","coronavirus","immunosuppression","psoriasis","treatment"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664636703986417664,"score":185.37053},{"pmid":32314483,"title":"COVID-19 and psoriasis : should we fear for patients treated with biologics?","text":["COVID-19 and psoriasis : should we fear for patients treated with biologics?","The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midts of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision. This article is protected by copyright. All rights reserved.","Dermatol Ther","Amerio, Paolo","Prignano, Francesca","Giuliani, Federica","Gualdi, Giulio","32314483"],"abstract":["The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midts of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Amerio, Paolo","Prignano, Francesca","Giuliani, Federica","Gualdi, Giulio"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314483","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13434","keywords":["biologics","covid-19","psoriasis","sars","therapy"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664714520167186432,"score":175.5317},{"pmid":32301363,"title":"Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.","text":["Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.","J Dermatolog Treat","Megna, M","Ruggiero, A","Marasca, C","Fabbrocini, G","32301363"],"journal":"J Dermatolog Treat","authors":["Megna, M","Ruggiero, A","Marasca, C","Fabbrocini, G"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301363","week":"202016|Apr 13 - Apr 19","doi":"10.1080/09546634.2020.1757605","keywords":["covid-19","biologic treatment","psoriasis","psoriasis management"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664635401293266944,"score":138.17685},{"pmid":32343839,"title":"The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience.","text":["The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience.","The \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID-19) and satisfying the epidemiological criteria for a pandemic [1]. As of April 1, 2020, more than one million COVID-19 positive cases have been identified and more than 54,000 deaths have occurred worldwide [2]. In Italy, 110,574 positive cases, 49,285 hospitalized patients and 13,155 deaths out of a population of 60,359,546 inhabitants, have been reported, respectively [3]. The highest number of deaths occurred in the northern Italian regions, i.e. Lombardy, Emilia-Romagna, Veneto and Piedmont [3].","Br J Dermatol","Gisondi, P","Facheris, P","Dapavo, P","Piaserico, S","Conti, A","Naldi, L","Cazzaniga, S","Malagoli, P","Costanzo, A","32343839"],"abstract":["The \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID-19) and satisfying the epidemiological criteria for a pandemic [1]. As of April 1, 2020, more than one million COVID-19 positive cases have been identified and more than 54,000 deaths have occurred worldwide [2]. In Italy, 110,574 positive cases, 49,285 hospitalized patients and 13,155 deaths out of a population of 60,359,546 inhabitants, have been reported, respectively [3]. The highest number of deaths occurred in the northern Italian regions, i.e. Lombardy, Emilia-Romagna, Veneto and Piedmont [3]."],"journal":"Br J Dermatol","authors":["Gisondi, P","Facheris, P","Dapavo, P","Piaserico, S","Conti, A","Naldi, L","Cazzaniga, S","Malagoli, P","Costanzo, A"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32343839","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/bjd.19158","keywords":["covid-19","biologics","interstitial pneumonia","psoriasis"],"locations":["Italy","Italian","Veneto","Piedmont"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1665351883864145921,"score":126.85206},{"pmid":32246966,"pmcid":"PMC7118699","title":"COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.","text":["COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.","J Am Acad Dermatol","Kansal, Naveen Kumar","32246966"],"journal":"J Am Acad Dermatol","authors":["Kansal, Naveen Kumar"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246966","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.jaad.2020.03.079","keywords":["biologics","covid-19 pandemic","psoriasis","syphilis"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664638040192057344,"score":125.49203}]}